ImmunoPrecise Antibodies Other Operating Income or Expenses 2022-2025 | IPA
ImmunoPrecise Antibodies other operating income or expenses from 2022 to 2025. Other operating income or expenses can be defined as the aggregate amount of all operating expenses either too small to report separately or that cannot be standardized into another Zacks field.
| ImmunoPrecise Antibodies Annual Other Operating Income or Expenses (Millions of US $) |
|
|---|---|
| 2024 | $0 |
| 2023 | $0 |
| 2022 | $-5 |
| 2021 | $-2 |
| ImmunoPrecise Antibodies Quarterly Other Operating Income or Expenses (Millions of US $) |
|
|---|---|
| 2025-01-31 | $0 |
| 2024-10-31 | |
| 2024-07-31 | |
| 2024-04-30 | |
| 2024-01-31 | |
| 2023-10-31 | |
| 2023-07-31 | |
| 2023-04-30 | |
| 2023-01-31 | |
| 2022-10-31 | |
| 2022-07-31 | $-1 |
| 2022-04-30 | $-2 |
| 2022-01-31 | $-1 |
| 2021-10-31 | $-1 |
| 2021-07-31 | $-1 |
| 2021-04-30 | |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | MEDICAL INFO SYS | $0.021B | $0.018B |
| ImmunoPrecise Antibodies Ltd. is a technology platform company with end-to-end solutions empowering companies to discover and develop therapies against any disease. ImmunoPrecise Antibodies Ltd. is based in VICTORIA. | |||